Vaccination against SARS-CoV-2 and disease enhancement–knowns and unknowns
RM Zellweger, TA Wartel, F Marks, M Song… - Expert review of …, 2020 - Taylor & Francis
Introduction The world is currently fighting a COVID-19 pandemic, perhaps the most
disruptive infectious disease outbreak since the 1918 Spanish influenza. Governments have …
disruptive infectious disease outbreak since the 1918 Spanish influenza. Governments have …
[HTML][HTML] SARS-CoV-2 vaccines: status report
F Amanat, F Krammer - Immunity, 2020 - cell.com
SARS-CoV-2, the causal agent of COVID-19, first emerged in late 2019 in China. It has since
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
infected more than 870,000 individuals and caused more than 43,000 deaths globally. Here …
Challenges and issues of anti-SARS-CoV-2 vaccines
S Blumental, P Debré - Frontiers in Medicine, 2021 - frontiersin.org
At the beginning of 2021, anti-SARS-CoV-2 vaccination campaigns had been launched in
almost 60 countries with more than 500 million doses having been distributed. In addition to …
almost 60 countries with more than 500 million doses having been distributed. In addition to …
COVID-19 vaccine boosters: the good, the bad, and the ugly
Pursuing vaccinations against COVID-19 brings hope to limit the spread of SARS-CoV-2
and remains the most rational decision under pandemic conditions. However, it does not …
and remains the most rational decision under pandemic conditions. However, it does not …
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations
J Sultana, G Mazzaglia, N Luxi… - Expert review of …, 2020 - Taylor & Francis
ABSTRACT Introduction Coronavirus disease (COVID-19), caused by severe acute
respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world …
respiratory syndrome coronavirus (SARS-CoV-2), has quickly spread around the world …
SARS-CoV-2 targets and COVID-19 vaccines
AW Currier, MC Jeshurin, VB Sampson - COVID, 2021 - mdpi.com
Coronavirus disease-2019 (COVID-19) vaccines are being used across the globe to reduce
the risk of developing COVID-19, stop the transmission of severe acute respiratory syndrome …
the risk of developing COVID-19, stop the transmission of severe acute respiratory syndrome …
COVID‐19 vaccinations: the unknowns, challenges, and hopes
The entire world has been suffering from the coronavirus disease 2019 (COVID‐19)
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …
The 2020 pandemic: current SARS-CoV-2 vaccine development
SO Alturki, SO Alturki, J Connors, G Cusimano… - Frontiers in …, 2020 - frontiersin.org
Coronaviruses are enveloped viruses with a positive-sense single-stranded RNA genome
infecting animals and humans. Coronaviruses have been described more than 70 years ago …
infecting animals and humans. Coronaviruses have been described more than 70 years ago …
Exploring the COVID-19 vaccine candidates against SARS-CoV-2 and its variants: where do we stand and where do we go?
ABSTRACT As of September 2021, 117 COVID-19 vaccines are in clinical development,
and 194 are in preclinical development as per the World Health Organization (WHO) …
and 194 are in preclinical development as per the World Health Organization (WHO) …
COVID-19 vaccination: from interesting agent to the patient
A Daou - Vaccines, 2021 - mdpi.com
The vaccination for the novel Coronavirus (COVID-19) is undergoing its final stages of
analysis and testing. It is an impressive feat under the circumstances that we are on the …
analysis and testing. It is an impressive feat under the circumstances that we are on the …